Bullous Pemphigoid-like Skin Eruption during Treatment with Rivaroxaban: A Clinical Case Study [PDF]
, 2018 Little has been documented about hypersensitivity reactions caused by treatment with rivaroxaban. This paper reports a bullous pemphigoid-like skin eruption that occurred in a 76-year-old female patient during rivaroxaban treatment.
Almeida Ribeiro, Jose +4 more
core +2 more sources
An infant with bullous pemphigoid
Dermatology Online Journal, 2007 Bullous pemphigoid is the most common subepidermal autoimmune blistering disease. However, it is very rare in the pediatric population. A 5-month-old male infant presented with multiple bullae located on palms and soles. Complete blood count revealed relative eosinophilia .
Santos, António Luís +4 more
openaire +5 more sources
Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis.
JAMA dermatology, 2020 Importance The association between the use of medications and the development of bullous pemphigoid (BP) is unclear. Objective To assess the associations between previous exposure to certain medications and BP. Data Sources For this systematic review
Sian-De Liu, Wei-Ti Chen, C. Chi
semanticscholar +1 more source
Lower Extremity Salvage in the Setting of Bullous Pemphigoid Exacerbation: A Case Report
Plastic and Reconstructive Surgery, Global Open, 2021 Summary:. Bullous pemphigoid is an autoimmune blistering disease where patients suffer from painful bullae, often covering large portions of the skin and requiring management with immune-suppression.
Samara E. Pollock, MD +5 more
doaj +1 more source
Bullous pemphigoid and autoimmunity
Journal of the American Academy of Dermatology, 1993 There are many case reports of bullous pemphigoid (BP) in association with a variety of autoimmune disorders, but no large case controlled studies have been performed.Our purpose was to determine whether there is an increased incidence of autoimmune disorders in patients with BP and whether there is a particular haplotype associated with this.A total ...
Taylor, G +3 more
openaire +4 more sources
Clinical Relevance of Autoantibodies in Patients with Autoimmune Bullous Dermatosis
Clinical and Developmental Immunology, 2012 The authors present their experience related to the diagnosis, treatment, and followup of 431 patients with bullous pemphigoid, 14 patients with juvenile bullous pemphigoid, and 273 patients with pemphigus.
Lilla Mihályi +4 more
doaj +1 more source
Dupilumab for bullous pemphigoid with intractable pruritus [PDF]
, 2019 Bullous pemphigoid (BP) is an autoimmune blistering disorder that predominantly affects the elderly. Treatment regimens typically include topical and systemic immunosuppressive medications.
Eichenfield, Dawn Z +2 more
core
The Syk tyrosine kinase is required for skin inflammation in an in vivo mouse model of epidermolysis bullosa acquisita [PDF]
, 2017 The inflammatory form of epidermolysis bullosa acquisita is caused by autoantibodies against type VII collagen (C7), a component of the dermal-epidermal junction.
Mócsai, Attila +3 more
core +1 more source
The Complex Role of IL‐13 in Bullous Pemphigoid: New Insights From a Retrospective Cohort Study
JEADV Clinical Practice, EarlyView.ABSTRACT Background Bullous pemphigoid (BP) is the most common autoimmune blistering skin disease, primarily affecting the elderly. The role of interleukin‐13 (IL‐13) in BP pathogenesis remains unclear, particularly regarding its potential as a therapeutic target.
Marwan Dawood +6 more
wiley +1 more source
A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis
Journal of Dermatological TreatmentAim: Bullous pemphigoid induced by secukinumab in treatment of psoriasis is rare.Methods: We report a 49-year-old man with psoriasis who developed bullous pemphigoid during treatment with secukinumab.Results: Scattered tense vesicles with itching ...
Guanghan Wang +3 more
doaj +1 more source